Compare Edwards Lifesciences Corporation Common Stock (EW) vs Tidewater Inc (TDW) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Edwards Lifesciences Corporation Common Stock vs Tidewater Inc — how do they compare? Edwards Lifesciences Corporation Common Stock trades at $84.25 (market cap $49.44B), while Tidewater Inc trades at $86.94 (market cap $4.15B). The key difference: Edwards Lifesciences Corporation Common Stock is far larger — about 11.9× Tidewater Inc's market cap, and Tidewater Inc is trading nearer its 52-week high, Edwards Lifesciences Corporation Common Stock nearer its low. Which is the better fit depends on your goals.
| EW | TDW | |
|---|---|---|
Market Cap | $49.44B | $4.15B |
Volume | 3,508,027 | 662,838 |
Sector | Health | Energy |
52-Week High | $95.18 | $100.61 |
52-Week Low | $72.65 | $47.29 |
Enterprise Value | $45.90B | $4.19B |
Typical Hold Time | — | 25 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Tidewater (TDW) trades at $83.40, up 1.62% with a bullish technical outlook supported by moving averages. The company maintains strong profitability with 18.34% net margins and 19.49% ROE, though recent Q2 2026 earnings missed expectations. Recent developments include the completion of Wilson Sons Ultratug acquisition in August 2026 and significant institutional buying from BlackRock.
TDW presents a mixed outlook with solid fundamentals but recent earnings volatility. The 26% upside to consensus price target of $105.50 offers potential, though execution risks from integration challenges and competitive pressures warrant caution. Institutional accumulation and bullish technicals support near-term strength.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Edwards Lifesciences Corporation Common Stock
Edwards Lifesciences develops medical technologies for structural heart disease. Its products include transcatheter aortic-valve replacement, mitral and tricuspid therapies, and surgical structural-heart technologies.
Read more on EW →About Tidewater Inc
Tidewater is the leading global provider of offshore support vessels (OSVs) to the energy industry. With the world's largest fleet of platform supply vessels (PSVs) and anchor handling tugs (AHTS), it provides critical logistics and marine support for offshore oil, gas, and renewable energy projects. Following a period of massive strategic consolidation, Tidewater is now focused on maximizing day rates and free cash flow in a supply-constrained market, positioning itself as a primary beneficiary of the multi-year offshore upcycle.
Read more on TDW →
